IMMU-50. A NOVEL CHIMERIC MODEL TO ACCURATELY IDENTIFY TAMMs IN GLIOBLASTOMA
Amir Saam Youshani(University of Manchester), Brian Bigger(University of Manchester), Hannah K. Shorrock(University of Manchester), Andrew S. MacDonald(University of Manchester), Peter J. Cook(Memorial Sloan Kettering Cancer Center), Federico Roncaroli(Manchester Academic Health Science Centre), Christopher Waugh(University of Manchester), Omar Pathmanaban(Manchester Academic Health Science Centre), Ian Kamaly-Asl(Royal Manchester Children's Hospital), Claire O’Leary(Royal College of Surgeons in Ireland), Kenny Yu(Memorial Sloan Kettering Cancer Center), Aiyin Liao(University of Manchester), Fiona L. Wilkinson(Manchester Metropolitan University)
Cited by 0
Related Papers
Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity
|Nature Cancer|2021|334
Circadian clock component REV-ERBα controls homeostatic regulation of pulmonary inflammation
|Journal of Clinical Investigation|2018|208
IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection
|Mucosal Immunology|2016|206